Amarin Reports Record Fourth Quarter and Full Year 2019 Financial Results and Provides Update on Operations

Go back to Amarin Reports Record Fourth Quarter and Full Year 2019 Financial Results and Provides Update on Operations

Amarin Corp. (AMRN) Tops Q4 EPS by 4c, Revs Beat; Reaffirms

February 25, 2020 4:12 PM EST

Amarin Corp. (NASDAQ: AMRN) reported Q4 EPS of $0.02, $0.04 better than the analyst estimate of ($0.02). Revenue for the quarter came in at $143.3 million versus the consensus estimate of $136.01 million.

2019 was a transformational year for Amarin and for preventative cardiovascular patient care, commented John Thero, Amarins... More